The company Moderna, one of several testing COVID-19 vaccines, announced its own product appeared to be 94.5 per cent effective, according to preliminary data, the second company on track to seek permission within weeks for emergency use. The announcement came as delays continued by the Trump administration in providing president-elect Biden with information on vaccine production. It’s also reported President Donald Trump’s campaign has dropped a key claim in their lawsuit challenge in Pennsylvania.
Politics
Coronavirus: Moderna announces vaccine is 94.5% effective as delays continue in U.S. transition after election
More Videos
-
Carney pledges solidarity with Jewish community in wake of Bondi Beach terror attack
-
The West Block: Dec. 14
-
Venezuela’s generals essentially ‘oligarchs,’ former Canadian Ambassador says
-
Looking into social media accounts at U.S. border ‘pretty concerning’: former border agent
-
‘That’s no big deal’: Trump reacts to latest Epstein photo dump
-
MPs, constituents react to Michael Ma’s floor crossing
You are viewing an Accelerated Mobile Webpage.
View Original Article